Human Growth Hormone Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Human Growth Hormone Market Size Analysis and Top Companies

The global human growth hormone market size is estimated at to hit around USD 20.78 billion by 2033 from USD 7.20 billion in 2024 with a CAGR of 12.5% from 2024 to 2033. The top companies operating in the human growth hormone market are Novo Nordisk, Merck & Co., Eli Lilly & Company, Pfizer Inc., Teva Pharmaceutical Industries, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, Roche, Ipsen, Ferring BV, and others.

Market Scope

Human Growth Hormone Market Companies

• Novo Nordisk
• Merck & Co.
• Eli Lilly & Company
• Pfizer Inc.
• Teva Pharmaceutical Industries
• Novartis AG
• Anhui Anke Biotechnology (Group) Co., Ltd
• Roche
• Ipsen

Recent Developments

• February 2021: The Pfizer and OPKO Health Inc. announced that the European Medicines Agency has authorised Somatrogon for the treatment of individuals lacking in juvenile growth hormone. Pfizer and OPKO have been working together to develop and market Somatrogon for GHD therapy since 2014.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344